A Nation-wide, retrospective study of cohort of patients with venous thromboembolism treated with rivaroxaban or vitamin K antagonists.

Trial Profile

A Nation-wide, retrospective study of cohort of patients with venous thromboembolism treated with rivaroxaban or vitamin K antagonists.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Mar 2017

At a glance

  • Drugs Rivaroxaban (Primary) ; Vitamin K antagonists (Primary)
  • Indications Venous thromboembolism
  • Focus Adverse reactions
  • Most Recent Events

    • 16 Mar 2017 Results (n=18416) published in the Thrombosis and Haemostasis
    • 22 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top